Study Evaluating GSI-953 in Healthy Young and Alzheimer's Patients

NCT00479219 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: GSI-953
OTHER: Placebo

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer